User profiles for Karthik Nagapudi
Karthik NagapudiDistinguished Scientist, Genentech Verified email at gene.com Cited by 5347 |
Engineered collagen–PEO nanofibers and fabrics
L Huang, K Nagapudi, R P. Apkarian… - Journal of biomaterials …, 2001 - Taylor & Francis
Type I collagen-PEO fibers and non-woven fiber networks were produced by the electrospinning
of a weak acid solution of purified collagen at ambient temperature and pressure. As …
of a weak acid solution of purified collagen at ambient temperature and pressure. As …
Photo-cross-linking of type I collagen gels in the presence of smooth muscle cells: mechanical properties, cell viability, and function
WT Brinkman, K Nagapudi, BS Thomas… - …, 2003 - ACS Publications
The effectiveness of photomediated cross-linking of type I collagen gels in the presence of
rat aortic smooth muscle cells (RASMC) as a method to enhance gel mechanical properties …
rat aortic smooth muscle cells (RASMC) as a method to enhance gel mechanical properties …
Correlating the structure and gene silencing activity of oligonucleotide-loaded lipid nanoparticles using small-angle X-ray scattering
With three FDA-approved products, lipid nanoparticles (LNPs) are under intensive development
for delivering wide-ranging nucleic acid therapeutics. A significant challenge for LNP …
for delivering wide-ranging nucleic acid therapeutics. A significant challenge for LNP …
Manufacture of pharmaceutical co‐crystals using twin screw extrusion: A solvent‐less and scalable process
Pharmaceutical scientists are currently facing an increasing number of drug molecules with
less than ideal properties such as poor solubility and lack of acceptable physical and …
less than ideal properties such as poor solubility and lack of acceptable physical and …
Viscoelastic and mechanical behavior of recombinant protein elastomers
K Nagapudi, WT Brinkman, BS Thomas, JO Park… - Biomaterials, 2005 - Elsevier
Recombinant DNA synthesis was employed to produce elastin–mimetic protein triblock
copolymers containing chemically distinct midblocks. These materials displayed a broad range …
copolymers containing chemically distinct midblocks. These materials displayed a broad range …
Photomediated solid-state cross-linking of an elastin− mimetic recombinant protein polymer
K Nagapudi, WT Brinkman, JE Leisen, L Huang… - …, 2002 - ACS Publications
Solid-state cross-linking of elastin−mimetic fibers was investigated. Through available
lysine residues, an elastin−mimetic protein polymer, poly((Val-Pro-Gly-Val-Gly) 4 (Val-Pro-Gly-Lys-…
lysine residues, an elastin−mimetic protein polymer, poly((Val-Pro-Gly-Val-Gly) 4 (Val-Pro-Gly-Lys-…
[HTML][HTML] Using supercritical fluid technology as a green alternative during the preparation of drug delivery systems
Micro- and nano-carrier formulations have been developed as drug delivery systems for
active pharmaceutical ingredients (APIs) that suffer from poor physico-chemical, …
active pharmaceutical ingredients (APIs) that suffer from poor physico-chemical, …
[HTML][HTML] Application of twin screw extrusion in the manufacture of cocrystals, part I: four case studies
The application of twin screw extrusion (TSE) as a scalable and green process for the
manufacture of cocrystals was investigated. Four model cocrystal forming systems, Caffeine-Oxalic …
manufacture of cocrystals was investigated. Four model cocrystal forming systems, Caffeine-Oxalic …
Fast Surface Crystallization of Amorphous Griseofulvin Below T g
L Zhu, J Jona, K Nagapudi, T Wu - Pharmaceutical research, 2010 - Springer
Purpose To study crystal growth rates of amorphous griseofulvin (GSF) below its glass
transition temperature (T g ) and the effect of surface crystallization on the overall crystallization …
transition temperature (T g ) and the effect of surface crystallization on the overall crystallization …
Drug concentration asymmetry in tissues and plasma for small molecule–related therapeutic modalities
The well accepted “free drug hypothesis” for small-molecule drugs assumes that only the
free (unbound) drug concentration at the therapeutic target can elicit a pharmacologic effect. …
free (unbound) drug concentration at the therapeutic target can elicit a pharmacologic effect. …